Role of Misoprostol for therapeutic termination of pregnancy from 10 -28 weeks of gestation

Journal of the Pakistan Medical Association

Volumn 57, Issue 3, 2007, Pages 129-132

  Naz, Sobia ^a   Sultana, Nadra ^a  

^a FOUNDATION UNIVERSITY MEDICAL COLLEGE   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN F2 ALPHA; ABORTIVE AGENT; OXYTOCIC AGENT;

ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIARRHEA; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FEVER; HOSPITALIZATION; HUMAN; LABOR INDUCTION; MAJOR CLINICAL STUDY; NAUSEA; OUTCOME ASSESSMENT; PAIN; PREGNANCY; THERAPEUTIC ABORTION; UTERINE CERVIX DILATATION; UTERUS CONTRACTION; VAGINA BLEEDING; VOMITING; DOSE RESPONSE; DRUG COMBINATION; FOLLOW UP; GESTATIONAL AGE; INTRAVAGINAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; PREGNANCY COMPLICATION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, THERAPEUTIC; ADMINISTRATION, INTRAVAGINAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; INFUSIONS, INTRAVENOUS; MISOPROSTOL; OXYTOCICS; OXYTOCIN; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 34247860683     PISSN: 00309982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Blumenthal PD, Castleman LD, Jain JK. Abortion by labour induction. In: Paul M, lichtenberg ES, Grime DA, stubble field PG, eds. A clinician's Guide to Medical and Surgical Abortions. New York, NY: Churchill Livingstone, 1998: pp. 139-54.
2. Grimes DA. Management of Abortion. In: Rock JA, Thompson JD, eds. Telinde's Operative Gynaecology. Lippincot Raven, Philadelphia 1997; pp. 477-500.
3. Karim SM, Amy JJ. Interruption of pregnancy. In: Karim SM, ed's, Prostaglandins and Reproduction. Baltimore MD, University Park Press, 1975: pp. 77-148.
4. Hale RW, Zinberg S. Use of misoprostol in pregnancy. N Eng J Med 2001;344:59-60.
5. Induction of Labour. ACOG practice bulletin no. 10 Washington D.C: American College of Obstetrician and Gynecologists, Novermber 1999.
6. Song J. Use of Misoprostol in obstetrics and Gynaecology. Obstet Gynecol Surg 2000; 55: 503-10.
7. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and Pregnancy. N Engl J med 2001; 344: 38-47.
8. Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod 1998; 13:2962-5.
9. Singh K, Fong YF. Preparation of cervix for surgical termination of pregnancy in the first trimester. Hum Reprod.2000; 6:442-8.
10. Singh K, Fong YF, Prasad RN, Dong F. Vaginal Misoprostol for pre-abortion cervical priming: Is there an optimal evacuation time interval? Br J Obstet Gynaecol. 1999;106:266-9.
11. Hossain N, Soomro N, Umar A. Medical management of second trimester fetal demise with Misoprostol. J Coll Physicians Surg Pak 2002; 12: 735-7.
12. Srisomboon J, Pongpisuttinun S. Efficacy of intra-cervicovaginal misoprostol in second trimester pregnancy termination: a comparison between live and dead fetuses. J Obstet Gynaecol Res 1998; 24: 1-5.
13. Munthali J, Moodley J. The use of misoprostol for midtrimester therapeutic termination of pregnancy. Tropical Doctor 2001; 31: 157-61.
14. Herabutya Y, Chanvachakul B, Punyavachira P. Second trimester pregnancy termination: a comparison of 600 and 800ug of interavaginal misoprostol. J Obstet Gynaecol Res 2001; 27:125-8.
15. Expert meeting on misoprostol sponsored by Reproductive Health Technologies project and Gynuity Health Projects. Consensus statement: Instructions for use- Abortion Induction with misoprostol (Cytotec®) in pregnancies upto 9 weeks LMP,Washington DC. July 28.2003.
16. Jain JK, Harwood B, Meckstroth KR, Mishell DR. Early Pregnancy termination with vaginal misoprostol combined with loperomide and acetaminophen prophylaxis. Contraception 2001; 63: 217-21
17. Jain JK, Dutton C, Harwood B, Meckstroth KR, Mishell DR Jr. A prospective randomized, double-blinded, placebo-controlled trial, comparing miferpristone and vaginal misoprostol to vaginal misoprostol alone for elective termination of early pregnancy. Hum Reprod 2002; 17: 1477-82.
18. Jain JK, Meckstroth KR, Mishell DR. Early pregnancy termination with intravaginally administered sodium chloride solution -moistened misoprostol tablets: historical comparison with mifepristone and oral misoprostol. Am Obstet Gynecol 1999; 181: 1386-91.
19. Ghorab MN, Hewl BA. Second trimester termination of pregnancy by extra amniotic prostaglandins F2 or endocervical misoprostol, a comparative study. Acta Obstet Gynaecol Scan 1998; 77:429-32.
20. Sirimai K, Kiriwat O, Neungton S, Suvanich -Chati S. Misoprostol use for therapeutic abortion in Siriraj Hospital: the Year 2000. J Med Association Thai 2002; 85:416-23.
21. Choy. Hee L, Raynor BD. Misoprostol induction of labour among women with a history of cesarean delivery. Am J Obstet Gynaecol 2001; 184: 115-7.
22. Creinin MD. Randomized comparison of efficacy, acceptability and cost of medical versus surgical abortion. Contraception 2000; 62:117-24.
23. Wagaarachchi PT, Ashok PW, Smith NC, Templeton A. Medical management of early fetal demise using sublingual misoprostol. Br J Obstet Gyaecol 2002; 109:462-5.
24. Wagaraachchi PT, Ashok PW, Narvekar N, Smith NC, Templeton A. Medical management of early fetal demise using a combination of mifepristone and misoprostol. Hum Reprod 2001; 16: 1849-53.
25. Nielsen S, Hahlin M, Platz-Christensen JJ. Unsuccessful treatment of missed abortion with combination of an antiprogesterone and a prostaglandin E1 analogue. Br J Gynaecol 1997; 104: 1094-6.